V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330009387 | 330003004 | 0 | 10.6 | Neo-adjuvant (N) | 2013-08-03 | 2013-08-03 | EW EuroEwing 2012 Arm A VAC | null | null | 330000305 | NOT MATCHED |
| 330009388 | 330012310 | null | 7.1 | Curative (C) | 2018-05-24 | 2018-05-24 | EW EuroEwing 2012 Arm B VC | 02 | N | 330000310 | NOT MATCHED |
| 330009389 | 330003005 | 1.82 | null | Palliative (P) | 2018-01-18 | 2018-01-19 | EW EuroEwing 2012 Arm A VAC | 02 | null | 330000310 | NOT MATCHED |
| 330009390 | 330003006 | 1.8 | 15 | Palliative (P) | 2017-04-01 | 2017-07-11 | NB HRNBL-1 BUMEL MAT | N | N | 330000334 | NOT MATCHED |
| 330009391 | 330003006 | null | 73.2 | null | 2014-05-29 | 2014-05-29 | Cisplatin + Radiotherapy | null | Y | 330000334 | CISPLATIN + RT |
| 330009392 | 330003007 | 0 | 13.2 | Disease modification (D) | 2016-07-01 | 2016-07-02 | EW EuroEwing 2012 Arm A/B Zol Acid | N | null | 330000353 | NOT MATCHED |
| 330009393 | 330003011 | null | 15 | Curative (C) | 2017-06-18 | 2017-06-19 | NB HRNBL-1 COJEC Ind COURSE C | N | N | 330000353 | NOT MATCHED |
| 330009394 | 330007609 | null | 60.2 | Adjuvant (A) | 2015-05-30 | 2015-06-18 | Cisplatin + Radiotherapy | N | N | 330000388 | CISPLATIN + RT |
| 330009395 | 330012741 | null | 12.5 | Curative (C) | 2017-03-27 | 2017-10-09 | CNS GCT II Germinoma - Ifos Etop | N | Y | 330000390 | NOT MATCHED |
| 330009396 | 330003015 | 0 | 20.4 | Curative (C) | 2016-07-28 | 2016-07-30 | CNS LGG2004 03 vinc + carbo | 02 | N | 330000390 | NOT MATCHED |
| 330009397 | 330003018 | 0 | 21.8 | Neo-adjuvant (N) | 2017-06-18 | 2017-06-18 | NB HRNBL-1 COJEC Ind COURSE C | N | Y | 330000392 | NOT MATCHED |
| 330009398 | 330007613 | 0 | 15 | Neo-adjuvant (N) | 2015-07-14 | 2015-11-07 | NB HRNBL-1 Isotretinoin | N | null | 330000394 | NOT MATCHED |
| 330009399 | 330003022 | null | 11 | Adjuvant (A) | 2017-08-10 | 2017-08-10 | NB HRNBL-1 COJEC Ind COURSE C | 2 | Y | 330000397 | NOT MATCHED |
| 330009400 | 330003026 | 0 | 60.5 | Neo-adjuvant (N) | 2014-03-01 | 2014-03-14 | NB HRNBL-1 TVD | null | N | 330000410 | NOT MATCHED |
| 330009401 | 330003033 | null | 11.6 | Disease modification (D) | 2015-06-10 | 2015-07-04 | NB HRNBL-1 ch14.18/CHO only (trial) | 02 | N | 330000450 | NOT MATCHED |
| 330009403 | 330003039 | null | 43.5 | Curative (C) | 2015-03-27 | 2015-03-27 | NB HRNBL-1 COJEC Ind COURSE C | N | N | 330000511 | NOT MATCHED |
| 330009404 | 330003041 | 1.63 | null | Curative (C) | 2014-03-10 | 2014-03-11 | Cisplatin + Radiotherapy | N | N | 330000512 | CISPLATIN + RT |
| 330009405 | 330003043 | 0 | 46.7 | Curative (C) | 2013-03-13 | 2013-07-04 | NB HRNBL-1 ch14.18/CHO only (trial) | N | N | 330000516 | NOT MATCHED |
| 330009406 | 330003051 | 0 | 11.5 | Curative (C) | 2015-05-09 | 2015-05-09 | CNS GCT II Germinoma - Ifos Etop | null | Y | 330000539 | NOT MATCHED |
| 330009407 | 330003051 | 1.81 | null | Curative (C) | 2013-08-16 | 2013-09-13 | CISPLATIN + RT | 2 | Y | 330000539 | CISPLATIN + RT |
| 330009408 | 330003054 | null | 39.4 | Palliative (P) | 2016-11-02 | 2016-12-11 | EW EuroEwing 2012 Arm A VAC | Y | N | 330000549 | NOT MATCHED |
| 330009409 | 330003056 | 0.88 | 9.7 | Curative (C) | 2015-12-13 | 2015-12-21 | STS Non-Rhabdo EpSSG 2005 Ifos Dox | 01 | N | 330000581 | NOT MATCHED |
| 330009410 | 330003058 | 0 | 93.5 | Curative (C) | 2016-06-25 | 2017-01-31 | NB HRNBL-1 ch14.18/CHO only (trial) | Y | null | 330000589 | NOT MATCHED |
| 330009411 | 330003062 | null | 77.6 | Curative (C) | 2014-03-30 | 2014-03-30 | Cisplatin 100 + RT(H&N) 1 day | 02 | Y | 330000620 | CISPLATIN + RT |
| 330009412 | 330003065 | 0 | 11.6 | Curative (C) | 2017-04-17 | 2018-01-04 | CNS PNET III Vinc, Cyclo, Etoposide | null | N | 330000642 | NOT MATCHED |
| 330009413 | 330003068 | null | 14 | Curative (C) | 2015-03-13 | 2015-07-23 | NB HRNBL-1 Isotretinoin | Y | N | 330000643 | NOT MATCHED |
| 330009414 | 330003070 | null | 10.8 | Curative (C) | null | 2016-08-01 | NB HRNBL-1 COJEC Ind COURSE C | Y | N | 330000651 | NOT MATCHED |
| 330009415 | 330003073 | 1.71 | 24.1 | null | 2018-02-17 | 2018-02-21 | CNS PNET III Vinc, Cyclo, Etoposide | N | N | 330000652 | NOT MATCHED |
| 330009416 | 330003076 | 0 | 24.7 | Disease modification (D) | 2018-03-04 | 2018-03-20 | CNS GCT II | N | N | 330000673 | NOT MATCHED |
| 330009417 | 330003079 | null | null | Palliative (P) | 2015-03-22 | 2015-04-04 | NB Low/Interm risk guidelines CO | N | N | 330000684 | NOT MATCHED |
| 330009418 | 330003081 | 0 | 22.5 | Curative (C) | 2015-12-31 | 2015-12-31 | CNS LGG 2004 03 cons vinc + carbo | Y | null | 330000686 | NOT MATCHED |
| 330009419 | 330003085 | 0 | 86.05 | Curative (C) | 2014-11-07 | 2014-12-06 | ATG + Amsacrine + BUSULFAN + CYTARABINE + FLUDARABINE | N | null | 330000719 | NOT MATCHED |
| 330009420 | 330003086 | null | 69 | Curative (C) | 2016-10-12 | 2018-01-27 | Cisplatin + Radiotherapy | 02 | N | 330000742 | CISPLATIN + RT |
| 330009421 | 330003090 | 0 | 10.6 | Neo-adjuvant (N) | 2017-05-31 | 2017-05-31 | NB HRNBL-1 Isotretinoin | Y | null | 330000774 | NOT MATCHED |
| 330009422 | 330003092 | null | 12.3 | Curative (C) | 2014-12-09 | 2015-02-28 | ATG + Amsacrine + BUSULFAN + CYTARABINE + FLUDARABINE | Y | Y | 330000793 | NOT MATCHED |
| 330009423 | 330003095 | 1.13 | 11.6 | Curative (C) | 2014-06-11 | 2014-06-11 | CNS LGG 2004 03 cons vinc + carbo | null | N | 330000827 | NOT MATCHED |
| 330009424 | 330007653 | 0 | 12 | Curative (C) | 2015-09-18 | 2016-04-24 | NB HRNBL-1 Isotretinoin | 2 | N | 330000839 | NOT MATCHED |
| 330009425 | 330010168 | null | 15.6 | Curative (C) | null | 2014-12-20 | NB HRNBL-1 ch14.18/CHO(trial) +IL-2 | N | N | 330000855 | NOT MATCHED |
| 330009426 | 330003101 | 0 | 12.9 | Curative (C) | 2013-08-06 | 2013-08-06 | NB HRNBL-1 Isotretinoin | Y | null | 330000867 | NOT MATCHED |
| 330009427 | 330003104 | 0 | 11.1 | Neo-adjuvant (N) | 2013-10-31 | 2013-11-25 | AML TX Guide FLA | 01 | null | 330000868 | NOT MATCHED |
| 330009428 | 330003105 | 0.88 | 12.2 | Curative (C) | 2014-08-22 | 2014-08-30 | AML Downs haM | N | N | 330000884 | NOT MATCHED |
| 330009430 | 330003108 | 1.83 | 12.6 | Curative (C) | 2013-09-03 | 2013-09-03 | LCHIV Cont A | Y | N | 330000894 | NOT MATCHED |
| 330009431 | 330003112 | null | 25.7 | Curative (C) | 2014-07-17 | 2014-12-25 | NB 13 cis-RA (Isotretinoin) | Y | N | 330000909 | NOT MATCHED |
| 330009432 | 330003113 | 1.6 | 85.2 | Adjuvant (A) | 2014-12-11 | 2014-12-11 | Cisplatin + Radiotherapy | 02 | Y | 330000924 | CISPLATIN + RT |
| 330009433 | 330007664 | 1.71 | null | Curative (C) | 2017-11-05 | 2017-12-25 | Cisplatin + Radiotherapy | N | Y | 330000930 | CISPLATIN + RT |
| 330009434 | 330003116 | null | 42.3 | Curative (C) | null | 2014-08-02 | CNS LGG | N | Y | 330000933 | NOT MATCHED |
| 330009435 | 330003119 | 1.68 | 104 | Curative (C) | 2013-11-21 | 2013-12-13 | Cisplatin 100 + RT(H&N) 1 day | 02 | N | 330000951 | CISPLATIN + RT |
| 330009436 | 330003121 | 1.65 | 55.4 | Curative (C) | 2017-08-06 | 2017-08-20 | Cisplatin 100 + RT(H&N) 1 day | 02 | null | 330000957 | CISPLATIN + RT |
| 330009437 | 330003123 | 1.59 | 115 | Radical (R) | 2014-05-29 | 2014-05-29 | CISPLATIN + RT | N | Y | 330000980 | CISPLATIN + RT |
| 330009438 | 330003125 | 1.5 | 67 | Curative (C) | 2016-08-06 | 2016-08-10 | Cisplatin 100 + RT(H&N) 1 day | 2 | Y | 330000999 | CISPLATIN + RT |